Adult-onset hereditary myeloid malignancy and allogeneic stem cell transplantation.

allogeneic stem cell transplantation donor cell leukemia genetic testing germline mutation hereditary myeloid malignancy

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 19 07 2022
accepted: 31 08 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: epublish

Résumé

Hereditary myeloid malignancies, especially in adults or elderly persons, had been considered quite rare before the next-generation sequencing era; however, increased usage of clinical sequencing has revealed much higher prevalence of inherited myeloid malignancies.

Identifiants

pubmed: 36185231
doi: 10.3389/fonc.2022.997530
pmc: PMC9524153
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

997530

Informations de copyright

Copyright © 2022 Toya, Harada, Harada and Doki.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Oncol. 2018 Jun 20;36(18):1788-1797
pubmed: 29702001
J Clin Immunol. 2022 Feb;42(2):404-420
pubmed: 34893945
Blood. 2011 Feb 24;117(8):2469-75
pubmed: 21177436
Blood. 2015 Nov 26;126(22):2484-90
pubmed: 26492932
Biol Blood Marrow Transplant. 2018 Jun;24(6):1250-1259
pubmed: 29412158
Cancers (Basel). 2022 Jul 14;14(14):
pubmed: 35884491
Nat Commun. 2014 Aug 27;5:4770
pubmed: 25159113
Blood Adv. 2020 Mar 24;4(6):1131-1144
pubmed: 32208489
Rinsho Ketsueki. 2019;60(6):600-609
pubmed: 31281151
Am J Hematol. 2021 Nov 1;96(11):1450-1460
pubmed: 34390506
Leukemia. 2022 May;36(5):1203-1214
pubmed: 35354921
Fam Cancer. 2021 Oct;20(4):295-303
pubmed: 34057692
Blood Adv. 2022 Jan 25;6(2):528-532
pubmed: 34644397
J Clin Oncol. 2022 Jan 10;40(2):189-201
pubmed: 34793200
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Leuk Lymphoma. 2013 Jan;54(1):28-35
pubmed: 22691122
Blood. 2022 Aug 18;140(7):756-768
pubmed: 35443031
Nat Genet. 2011 Sep 04;43(10):1012-7
pubmed: 21892162
Hum Mol Genet. 2021 Oct 1;30(20):R225-R235
pubmed: 34100074
Br J Haematol. 2008 Jan;140(2):123-32
pubmed: 18173751
Nat Rev Cancer. 2021 Feb;21(2):122-137
pubmed: 33328584
Blood. 2022 Aug 18;140(7):716-755
pubmed: 35671390
Front Oncol. 2021 Jan 28;10:582213
pubmed: 33585199
Ann Hematol. 2016 Jan;95(2):301-10
pubmed: 26537612
Biol Blood Marrow Transplant. 2020 Jun;26(6):1124-1130
pubmed: 32088370
Blood. 2017 Apr 13;129(15):2070-2082
pubmed: 28179279
Int J Hematol. 2022 Jul;116(1):16-27
pubmed: 35633493
Bone Marrow Transplant. 2021 Nov;56(11):2732-2741
pubmed: 34244664
Br J Haematol. 2012 Jul;158(2):242-248
pubmed: 22533337
Blood. 2018 Nov 1;132(18):1994-1998
pubmed: 30232126
Haematologica. 2022 Feb 01;107(2):510-518
pubmed: 33626862
Hematol Oncol Clin North Am. 2018 Aug;32(4):657-668
pubmed: 30047418
Nat Genet. 2016 Jul;48(7):792-7
pubmed: 27182967
Blood. 2016 Mar 17;127(11):1387-97; quiz 1518
pubmed: 26702063
J Clin Invest. 2021 Jun 24;:
pubmed: 34166225
Cancer Sci. 2020 Sep;111(9):3367-3378
pubmed: 32619037
Blood. 2020 Jul 2;136(1):24-35
pubmed: 32430494
Leukemia. 2017 Apr;31(4):1020-1022
pubmed: 28194039
Cancer Med. 2020 Nov;9(21):7954-7963
pubmed: 32931654
Leukemia. 2022 Mar;36(3):664-674
pubmed: 34671111
Hemasphere. 2019 Nov 04;3(6):e321
pubmed: 31976490
JCO Precis Oncol. 2021 Nov;5:107-122
pubmed: 34994594
Blood. 2015 Sep 3;126(10):1214-23
pubmed: 26162409
Blood. 2016 Sep 15;128(11):1516-24
pubmed: 27313329
Front Oncol. 2022 Feb 01;12:806137
pubmed: 35178345
Br J Haematol. 2022 Mar;196(6):1293-1310
pubmed: 34658019
Biol Blood Marrow Transplant. 2014 Dec;20(12):1940-8
pubmed: 25111582
Platelets. 2014;25(4):300-2
pubmed: 23971860
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Blood. 2021 Nov 4;138(18):1733-1739
pubmed: 34115096
Cancer Cell. 2015 May 11;27(5):658-70
pubmed: 25920683
Expert Rev Hematol. 2018 Aug;11(8):625-636
pubmed: 29958021
Bone Marrow Transplant. 2021 Jul;56(7):1535-1549
pubmed: 33686252
Nat Genet. 2001 Mar;27(3):263-70
pubmed: 11242107
Ann Pharmacother. 2002 Dec;36(12):1971-2
pubmed: 12452763
Sci Rep. 2020 Aug 31;10(1):14297
pubmed: 32868804
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Br J Haematol. 2022 Jan;196(1):169-178
pubmed: 34580862
Leukemia. 2017 Feb;31(2):520-522
pubmed: 27795557
Ann Oncol. 2016 May;27(5):887-95
pubmed: 26884589
J Clin Oncol. 2008 Nov 1;26(31):5088-93
pubmed: 18768433
Leukemia. 2016 Aug;30(8):1742-5
pubmed: 26867671
Blood. 2019 Oct 24;134(17):1441-1444
pubmed: 31484648
Leukemia. 2016 Nov;30(11):2282
pubmed: 27804971
Blood. 2016 Nov 24;128(21):2497-2503
pubmed: 27881370
Leuk Lymphoma. 2022 May 9;:1-10
pubmed: 35533071
Blood Adv. 2022 Jan 11;6(1):238-247
pubmed: 34448807
J Clin Oncol. 2012 Sep 1;30(25):3109-18
pubmed: 22753902
Leuk Lymphoma. 2020 Jul;61(7):1688-1694
pubmed: 32157945
Blood. 2021 Mar 11;137(10):1428-1431
pubmed: 33075818
Blood. 2021 Sep 30;138(13):1137-1147
pubmed: 33951732
Blood. 2020 May 21;135(21):1882-1886
pubmed: 32315381
Am J Hematol. 2019 Jul;94(7):757-766
pubmed: 30963592
Blood Adv. 2018 Jan 23;2(2):146-150
pubmed: 29365323
Clin Immunol. 2020 Sep;218:108522
pubmed: 32682923
Int J Hematol. 2010 Jul;92(1):194-7
pubmed: 20549580
N Engl J Med. 2004 Dec 2;351(23):2403-7
pubmed: 15575056
Haematologica. 2018 Aug;103(8):1278-1287
pubmed: 29724903
Nat Genet. 1999 Oct;23(2):166-75
pubmed: 10508512
Leukemia. 2009 Jul;23(7):1364-6
pubmed: 19387465

Auteurs

Takashi Toya (T)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Hironori Harada (H)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy & Life Sciences, Tokyo, Japan.

Yuka Harada (Y)

Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Noriko Doki (N)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Classifications MeSH